2011
DOI: 10.1245/s10434-011-2103-7
|View full text |Cite
|
Sign up to set email alerts
|

A High Body Mass Index in Esophageal Cancer Patients Does Not Influence Postoperative Outcome or Long-Term Survival

Abstract: BackgroundThe body mass index (BMI) in the general population has increased over the past decades. A high BMI is a known risk factor for the development of esophageal adenocarcinoma. Several studies on the influence of a high BMI on the postoperative course and survival after esophagectomy have shown contradictory results. The aim of the present study was to determine the influence of a high BMI on postoperative complications and survival among a large cohort of esophageal cancer patients.MethodsPatients who u… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

10
46
4
1

Year Published

2012
2012
2020
2020

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 55 publications
(61 citation statements)
references
References 19 publications
10
46
4
1
Order By: Relevance
“…17 A more recent study from Europe found that BMI >25 kg/m 2 was not associated with worse outcomes in 215 patients undergoing oesophagectomy for cancer; specifically, there were no differences in operative times (median 280 min in both normal or high BMI), morbidity (49% vs 53%, p=0.4), mortality (8.3% vs 3.4%, p=0.1) and median number of harvested lymph node (14 vs 11, p=0.054). 18 Two recent studies by Blom et al 19 and Grotenhius et al 20 have both demonstrated that patients with elevated BMI do not experience an increase in operative outcomes or oncological outcomes. However, Blom and colleagues did demonstrate an increase in anastomotic leaks in the obese population, a finding which we did not corroborate.…”
Section: Discussionmentioning
confidence: 99%
“…17 A more recent study from Europe found that BMI >25 kg/m 2 was not associated with worse outcomes in 215 patients undergoing oesophagectomy for cancer; specifically, there were no differences in operative times (median 280 min in both normal or high BMI), morbidity (49% vs 53%, p=0.4), mortality (8.3% vs 3.4%, p=0.1) and median number of harvested lymph node (14 vs 11, p=0.054). 18 Two recent studies by Blom et al 19 and Grotenhius et al 20 have both demonstrated that patients with elevated BMI do not experience an increase in operative outcomes or oncological outcomes. However, Blom and colleagues did demonstrate an increase in anastomotic leaks in the obese population, a finding which we did not corroborate.…”
Section: Discussionmentioning
confidence: 99%
“…However, several recent studies in esophageal cancer patients all demonstrate that the total lymph node yield is not related to BMI. [31][32][33] These findings could potentially provide some indirect evidence that the meso-esophageal tissue volume also might not be related to the BMI.…”
Section: Limitationsmentioning
confidence: 89%
“…The main reasons for these conflicting reports include the different BMI cut-off values used across the different studies and the presence of confounding factors such as gender, age, comorbidities, histological type, neoadjuvant therapy, and smoking status [15][16][17] . The incidence of adenocarcinoma was higher in overweight and obese patients than that in normal weight patients [15,16] , and a significantly smaller percentage of obese patients received neoadjuvant chemotherapy compared with to the percentage of overweight and normal weight patients [16] . The prognostic impact of BMI stratified by smoking status was determined in patients with EAC; obesity in patients who had never smoked was independently associated with a 2-fold worsening of long-term survival after surgery [17] .…”
Section: Discussionmentioning
confidence: 99%